China Ophthalmic Hospital Industry Report, 2012-2015
  • May.2013
  • Hard Copy
  • USD $1,600
  • Pages:51
  • Single User License
    (PDF Unprintable)       
  • USD $1,500
  • Code: XJT032
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,300
  • Hard Copy + Single User License
  • USD $1,800
With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, with an AAGR of 7.1% during 2006-2011; industry revenue attained to RMB6.0515 billion, with a CAGR of 24.8% during 2006-2011. Following the rising demand, the total revenue of ophthalmic hospitals in future is still expected to grow at a rate of more than 20%.

Total Revenue of China Ophthalmic Hospital Industry, 2006-2015E

Among Chinese specialized hospital market segments, ophthalmic hospital enjoys higher level of technology and profit, i.e. gross profit hit RMB892.4 million in 2011, with a compound growth rate of 49.1% in 2006-2011; gross margin was 14.7%, much higher than 3.8% of the hospital industry. Due to the uneven medical level as well as the quite different reception capabilities of eye care institutions, there are some differences in the level of profitability. China’s largest eye institution - Aier Ophthalmology, for instance, reached gross margin of about 50.0% in 2008-2012, significantly higher than the industrial average.

As there exists certain service radius, China’s eye care service industry shows an obvious competition pattern of “national dispersion, regional concentration”. With respect to the current market share, Eye & ENT Hospital of Fudan University, Zhongshan Ophthalmic Center of Sun Yat-sen University and other public ophthalmic hospitals hold greater market shares locally; private hospitals such as Aier Ophthalmology and Bright Eye Hospital are rapidly expanding the chain of eye care services, accompanied by an increasing market share on a national scale.

China Ophthalmic Hospital Industry Report, 2012-2015 mainly covers the followings:

20120114.gif?Overview of ophthalmic hospital market in China, including changes in number, operation, current medical services, competition pattern, etc. of ophthalmic hospitals;
20120114.gif?Environment for the development of ophthalmic hospitals in China, involving regulatory system, industry policies, related policies that encourage the entry of private capital, upstream & downstream industry and impact, etc.;
20120114.gif?China ophthalmic hospital industry growth forecast, including the influence of Taiwan’s “Seal Knife Gate” on the industry, ophthalmic medical institution market size forecast, investment opportunities and risks for private ophthalmic hospitals, etc.;
20120114.gif?Operation, investment, merger & acquisition, development forecast concerning three major private hospitals, two Sino-foreign hospitals and six public hospitals in China.

1. Overview of Ophthalmic Hospital Industry in China
1.1 Definition
1.2 Main Business
1.3 Industry Characteristics

2. Overview of Ophthalmic Hospital Market in China
2.1 Number of Hospitals
2.1.1 Stable Growth in the Number of Hospitals
2.1.2 Faster Growth of Non-public Hospitals
2.2 Revenue
2.3 Profit Level
2.4 Medical Service
2.5 Competition Pattern
2.6 Barriers to Entry
2.6.1 Market Access
2.6.2 Medical Personnel
2.6.3 Industry Experience & Management Level
2.6.4 Capital Strength

3. Development Environment 
3.1 Policy Environment 
3.1.1 Industry Regulation
3.1.2 Industry Policy 
3.2 Upstream & Downstream Sectors
3.2.1 Upstream 
3.2.2 Downstream

4. Investment Analysis
4.1 “Seal Knife Gate” Impact Dissipates
4.1.1 “Seal Knife Gate” Event
4.1.2 “Seal Knife Gate” Impact 
4.1.3 Industry Will Be Integrated
4.2 Eye Care Market Forecast
4.2.1 Excimer Laser Surgery
4.2.2 Cataract Surgery
4.2.3 Potential Demand in Primary Market
4.2.4 Market Size Forecasting
4.3 Private Eye Hospitals Win Development Opportunities
4.3.1 Policy Support
4.3.2 Clear Competitive Edge
4.4 Ophthalmic Hospitals Have More Development Advantages 
4.5 Investment Risk
4.5.1 Medical
4.5.2 Social Cognition
4.5.3 Market Competition
4.5.4 Human Resources
4.5.5 Medical Service Price Volatility
4.5.6 Legal 

5. Major Hospitals 
5.1 Aier Ophthalmology
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Medical Business
5.1.6 Forecast & Outlook
5.2 BO-AI Medical Group of Ophthalmology
5.2.1 Profile
5.2.2 Development
5.3 Bright Eye Hospital
5.3.1 Profile
5.3.2 Development
5.4 Eyegood Ophthalmic
5.4.1 Profile
5.4.2 Development
5.5 Maige Ophthalmology
5.5.1 Profile
5.5.2 Development
5.6 Zhongshan Ophthalmic Center of Sun Yat-sen University
5.6.1 Profile
5.6.2 Development
5.7 Eye & ENT Hospital of Fudan University
5.7.1 Profile
5.7.2 Development
5.8 Xiamen Eye Center of Xiamen University
5.8.1 Profile
5.8.2 Development
5.9 Tianjin Eye Hospital
5.9.1 Profile
5.9.2 Development
5.10 The Affiliated Eye Hospital of Wenzhou Medical College
5.10.1 Profile
5.10.2 Development
5.11 Shanxi Eye Hospital
5.11.1 Profile
5.11.2 Development
Introduction to Main Business of Ophthalmic Hospitals in China
Number of Hospitals in China, 2006-2011
Number of Ophthalmic Hospitals in China and % in Total Number of Hospitals, 2006-2011
Number of Ophthalmic Hospitals in China (by Economic Type), 2006-2011
Total Revenue of China Ophthalmic Hospital Industry, 2006-2011
Gross Profit of China Ophthalmic Hospital Industry, 2006-2011
Average Gross Margin of Hospitals and Ophthalmic Hospitals in China, 2006-2011
Bed Occupancy Rate of Ophthalmic Hospitals in China, 2006-2011
Average Daily Outpatient Visits per Physician in Chinese Ophthalmic Hospitals, 2007-2011
Average Daily Hospital Beds per Physician in Chinese Ophthalmic Hospitals, 2007-2011
Policies on China’s Social Capital Entry into the Field of Medical Services, 2009-2012
Difference between Policies on Private Hospitals and Public Hospitals
Total Health Costs in China, 1980-2011
China’s Total Health Costs as a Percentage of GDP, 1985-2011
Total Expenditure on Health of Resident Individuals in China, 1980-2011
Per Capita Health Care Expenditure of Urban and Rural Residents in China, 1990-2011
Per Capita Health Care Expenditure of Urban and Rural Residents in China as a Percentage of Consumptive Expenditure, 1990-2011
Per Capita Disposable Income of Urban Residents and Per Capita Net Income of Rural Households in China, 2006-2012
Health Insurance System Structure in China
Population Coverage of Health Insurance in China, 2005-2011
Total Coverage of Health Insurance in China, 2005-2011
China’s Population aged 60 and over as a Percentage of Total Population, 2007-2013
Refractive Surgery Procedures and Market Price
Total Revenue of China Ophthalmic Hospital Industry, 2006-2015E
Important Events that Encourage the Development of Private Hospitals in China
Principal-agent Chain of Public Hospitals in China
Per Capita Treatment Cost in Private & Public Hospitals, 2012
Comparison of Specialized Medical Service Projects 
Revenue and Net Income of Aier Ophthalmology, 2008-2012
Revenue of Aier Ophthalmology by Product, 2008-2012
Revenue of Aier Ophthalmology by Region, 2008-2012
Gross Margin of Aier Ophthalmology by Product, 2008-2012
Revenue and Net Income of Aier Ophthalmology, 2011-2015
Introduction to Main Operating Agencies of BO-AI Medical Group of Ophthalmology
Introduction to Main Operating Agencies of Bright Eye Hospital

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号